[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582440":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":47,"collaborators":20,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":20,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":20,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Shanghai 6th People's Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"wearing continuous glucose monitorings","EXPERIMENTAL","Patients will wear two FreeStyle Libre Pro Flash CGM (Abbott Diabetes Care, Alameda, CA, USA) to ensure continuous tracking of blood glucose levels at key time points throughout the ovarian stimulation.",[13],"Device: CGM",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","CGM","Each patient will participate in the group only once and wear two FreeStyle Libre Pro Flash CGM (Abbott Diabetes Care, Alameda, CA, USA), which record glucose readings for up to 14 days.\n\nFollowing the initial consultation and before initiating the ovulation induction protocol, the first CGM sensor will be placed to collect baseline data. Upon entering the ovulation induction cycle, patients will return to the hospital on the 2nd or 3rd day of menstruation, at which point the first CGM sensor will be removed, and the second sensor will be applied. This second sensor will be removed after 14 days.\n\nIn summary, this protocol ensures continuous tracking of blood glucose levels at key time points throughout the ovarian stimulation.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Jian Zhou, Dr.","CONTACT","+86 021 24056515","zhoujian@sjtu.edu.cn",[28],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Shanghai Sixth People's Hospital","RECRUITING","Shanghai","Shanghai Municipality","200233","China","CN",{"type":37,"coordinates":38},"Point",[39,40],121.45806,31.22222,{"lat":40,"lon":39},[43],{"name":44,"role":24,"phone":45,"phoneExt":20,"email":46},"Li Cao, B.S.","+86 18800257949","caoli1558@126.com",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Jian Zhou","Principal Investigator, Professor, Chief Physician, Deputy Director","100582440","glucose-pattern-in-infertile-women-receiving-assisted-reproduction-using-continuous-glucose-monitoring-100582440",false,"NCT06863337","Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring","Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring","Inclusion Criteria:\n\n1. Informed consent and voluntary participation in this study;\n2. Age ≥ 18 years and ≤40 years old;\n3. Infertile patients who will undergo their first or second cycle of in vitro fertilization\u002Fintracytoplasmic sperm injection (IVF\u002FICSI) at the study center;\n4. The chosen ovulation promotion regimens is the GnRH antagonist regimen\u002Fprogesterone-promoting ovulation under hyperprogesterone state (PPOS) regimen.\n\nExclusion Criteria:\n\n1. Recent infections (excluding viral infections of the reproductive system such as HPV);\n2. Recent glucocorticoid treatment or chemotherapy;\n3. Clinical conditions affecting the outcome of assisted reproduction, including repeated implantation failure, recurrent spontaneous abortion, history of unilateral oophorectomy, uterine malformations, and parental karyotype abnormalities;\n4. Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area.","FEMALE","18 Years","40 Years",{"count":62,"type":63},100,"ESTIMATED","INTERVENTIONAL",[66],"NA","No studies have been seen on glucose variation during medication for assisted reproduction. The aim of this study is to continuously observe glucose variation during assisted reproduction treatment using continuous glucose monitoring (CGM), and to further explore whether glucose variation will affect the outcomes related to assisted reproduction.",[69],"Infertility Female","2025-12-21",{"date":72,"type":73},"2025-12-23","ACTUAL",{"date":75,"type":73},"2025-03-26",{"date":77,"type":63},"2027-04-30",{"name":5,"class":6},1]